Q: What is abevmy used for?
A: Abevmy is used to deal with diverse styles of cancer, which include metastatic colorectal cancer, non-small cell lung cancer, glioblastoma, renal cellular carcinoma, and cervical cancer.
Q: How does abevmy work?
A: Abevmy is a monoclonal antibody that works by blocking the movement of vascular endothelial increase factor (VEGF), a protein that promotes the boom of new blood vessels. Through blockading VEGF, abevmy facilitates sluggish or prevents the growth and spread of most cancer cells.
Q: How is abevmy given?
A: Abevmy is given by injection into a vein (intravenous infusion) by way of a healthcare provider in a health center or medical institution placing.
Q: What are the aspect effects of abevmy?
A: Commonplace side results of abevmy consist of excessive blood strain, headache, nausea, diarrhea, vomiting, fatigue, reduced urge for food, and mouth sores. Greater critical facet effects can include bleeding, blood clots, perforation of the belly or intestines, and coronary heart problems. It is critical to document any side outcomes to your health practitioner.